United States · FDA National Drug Code directory
Rotarix
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58160-740_8bc5afc0-e90f-4404-8379-06e456cfd1cc
- Product NDC
- 58160-740
- Form
- SOLUTION
- Composition / generic term
- Rotavirus Vaccine, Live, Oral
- Labeler
- GlaxoSmithKline Biologicals SA
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230201
- Source listing expiry
- 20271231
Source-listed ingredients
- HUMAN ROTAVIRUS A TYPE G1P(8) STRAIN RIX4414 LIVE ANTIGEN — 1000 [CCID_50]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 APPLICATOR in 1 CARTON (58160-740-21) / 1.5 mL in 1 APPLICATOR (58160-740-02) · 58160-740-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →